Older adults taking GLP-1 receptor agonists, primarily semaglutide (Rybelsus, Ozempic, Wegovy), had a small uptick in their ...

In this randomized controlled trial, oral semaglutide significantly reduced the risk of adverse cardiovascular events in ...

Currently, the only approved treatment for MASH on the market is the thyroid hormone receptor β agonist resmetirom (Rezdiffra ...

Over the past decade, the global pharmaceutical industry has witnessed a transformation in the treatment landscape for ...

In just a short span of time, Ozempic, also popularly known as the ‘miracle’ weight loss drug, has become the talk of the ...

Are you tired of boring dieting and gruesome workouts? Then, medical weight loss treatment can be a solution for you. But ...

ANSWER: Both prediabetes and diabetes are metabolic abnormalities in which the body cannot use sugar properly. There are ...

In people with diabetes, Farxiga drops A1C levels by roughly 0.6%, which is not a huge amount compared to other diabetes ...

Among patients who experienced an early cardiovascular event, those treated with semaglutide had approximately 40% fewer ...

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...

Weight loss drugs have become an increasingly popular, but controversial, way of quickly shedding extra pounds over the past ...